Prof. Dr. Shuangli Mi is currently working as principal investigator in Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformation. She received her Ph.D. in Peking University, Beijing, China. She got her postdoctoral training in University of Chicago to study the mechanisms for microRNAs regulation in acute leukemia in Dr. Janet D. Rowley Laboratory and pharmacogenomics for personalized medicine in Dr. Eileen Dolan Laboratory. She is a multi-disciplinary scientist and has made achievements in many fields of research. She is now focusing on the epigenetic roles of non-coding RNAs in carcinogenesis and tumor progression, especially in exosome secreted by cancers, and identifying novel biomarkers for cancer diagnosis and prognosis. She is also working on metagenomics including development of novel methods and the relationship between intestinal flora imbalance and complex diseases.